Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/2007
06/07/2007US20070129297 Treatment and prevention of asthma
06/07/2007US20070129296 Cardiac muscle function and manipulation
06/07/2007US20070129294 Compound and method of treatment
06/07/2007US20070129293 Tissue protective cytokines for the treatment and prevention of sepsis and the formation of adhesions
06/07/2007US20070129292 Treatment of aspergillus infections with alpha thymosin peptides
06/07/2007US20070129291 Genobix agonists and antagonists for use in the treatment of metabolic disorders
06/07/2007US20070129290 Metabolite derivatives of the HDAC inhibitor FK228
06/07/2007US20070129289 Deoxo-proline-containing tamandarin and didemnin analogs, dehydro-proline-containing tamandarin and didemnin analogs, and methods of making and using them
06/07/2007US20070129288 Antibacterial amide macrocycles
06/07/2007US20070129287 Hemoglobin conjugates
06/07/2007US20070129286 Treatment Solution and Method for Preventing Posterior Capsular Opacification by Selectively Inducing Detachment And/Or Death of Lens Epithelial Cells
06/07/2007US20070129285 Protein a compositions and methods of use
06/07/2007US20070129284 Single-chain insulin
06/07/2007US20070129283 Compositions and methods for reducing food cravings
06/07/2007US20070129282 Pharmaceutical treatments and compositions
06/07/2007US20070129281 Pharmaceutical compounds
06/07/2007US20070128721 Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
06/07/2007US20070128701 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon
06/07/2007US20070128699 Using formation of binding complex between oncogenic human papilloma viral protein E6 and PDZ domain protein as diagnostic indicator of cell proliferative disorders
06/07/2007US20070128698 Peptide constructs for treating autoimmune and related diseases
06/07/2007US20070128695 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
06/07/2007US20070128672 Complementarity determining region (CDR); cancer, rheumatoid arthritis; immunology
06/07/2007US20070128667 Secreted neural apoptosis inhibiting proteins
06/07/2007US20070128662 Photoreactive regulator of protein function and methods of use thereof
06/07/2007US20070128657 Molecular libraries
06/07/2007US20070128653 Human HAC3
06/07/2007US20070128648 Methods for the Identification of IKKalpha Function and other Genes Useful for Treatment of Inflammatory Diseases
06/07/2007US20070128630 Identifying a T-cell epitope in protein, modifying protein to neutralize T-cell epitope such that the modified protein induces less than or substantially equal the baseline proliferation of naive T-cells, and wherein the allergenicity of protein is reduced
06/07/2007US20070128627 A carrier and a steroid receptor coactivator-1 and transcription intermediary factor-2 Associated Modulatory Protein (STAMP) that can modulate transcription of glucocorticoid-, progesterone-, mineralocorticoid- and androgen-responsive genes; conception (contraception), infertility, diabetes, cancer etc
06/07/2007US20070128604 Variants of human taste receptor genes
06/07/2007US20070128595 Novel polynucleotide and polypeptide sequences and uses thereof
06/07/2007US20070128591 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer
06/07/2007US20070128585 (+)-trans-4-(1-aminoethyl)-1-(4-pyridycarbamoyl)-cyclohexane and method for promoting neural growth in the central nervous system and in a patient at a site of neuronal lesion
06/07/2007US20070128299 Functional beverage and composition
06/07/2007US20070128294 Treatment and prevention of liver adverse conditions using gallium
06/07/2007US20070128291 Method and Apparatus for Forming Chromonic Nanoparticles
06/07/2007US20070128265 Regulation of cell proliferation and differentiation using topically applied peptides
06/07/2007US20070128259 AL-2 neurotrophic factor
06/07/2007US20070128252 Compositions and methods for treatment of body weight conditions
06/07/2007US20070128249 Osteogenic paste compositions and uses thereof
06/07/2007US20070128245 Porous calcium phosphate bone material
06/07/2007US20070128231 Phosphate-buffered solution with a pH of 5.9 to 6.8 containing tris(hydroxymethyl)aminomethane as a stabilizer; does not contain amino acids or human serum albumin; may also contain NaCl, ethylenediaminetetraacetic acid, and a nonionic detergent such as a polysorbate
06/07/2007US20070128227 Multi-step therapy for injured muscles
06/07/2007US20070128218 Diagnosis and treatment of hepatic disorders
06/07/2007US20070128203 Anti-integrin antibodies, compositions, methods and uses
06/07/2007US20070128198 Compositions comprising antibodies to human fgl2
06/07/2007US20070128195 Interleukins; Antigen binding fragment that binds to polypeptide of given sequence; immunogenic
06/07/2007US20070128193 GLP-1 agonists, compositions, methods and uses
06/07/2007US20070128188 For stimulating release of tumor necrosis factor and/or cellular prolifefration/differentiation of chondrocytes by contacting blood w/polypeptide; diagnosis cancer
06/07/2007US20070128187 modulating lipid levels and/or bone mass; diagnosis of abnormal lipid levels and bone mass disorders, such as osteoporosis; bone disorders; Paget's disease
06/07/2007US20070128186 Proliferative glomerulonephritis-related gene
06/07/2007US20070128185 Identification of unique binding interactions between certain antibodies and the human b7.1 and b7.2 co-stimulatory antigens
06/07/2007US20070128182 Non-Surgical Method for Preventing or Reducing the Rate of the Progression of Non-Proliferative Diabetic Retinopathy and the Treatment of Other Ocular Conditions
06/07/2007US20070128181 Administering within 12 hours after cardiac surgery to patient a blood clotting inhibitor such as a combination of dipyridamole and aspirin, wherein cardiac surgery does not include vein graft coronary artery bypass graft surgery; decreases complications without significant adverse effects; efficiency
06/07/2007US20070128180 Heat resistant hydrolase for use in preparation of dairy products
06/07/2007US20070128179 Phospholipase(s) and use(s) thereof
06/07/2007US20070128176 Stem cells of the islets of langerhans and their use in treating diabetes mellitus
06/07/2007US20070128175 Novel hydorgels and uses thereof
06/07/2007US20070128169 Inhibition of gene expression by delivery of polynucleotides to animal cells in vivo
06/07/2007US20070128167 Complexing agents for compositions containing inclusion complexes
06/07/2007US20070128166 Expression vector comprising cytomegalo virus promoter, tumor suppressor region, terminal repeat and conditional sucide gene sequences for use in targeting and destruction of tumor cells; antitumor agents; gene therapy
06/07/2007US20070128163 Adeno-associated virus-mediated delivery of angiogenic factors
06/07/2007US20070128162 Alpha interferon variants
06/07/2007US20070128161 Methods of treating cancer using IL-21
06/07/2007US20070128160 Methods for treating viral infection using il-28 and il-29
06/07/2007US20070128159 Chemokines as adjuvants of immune response
06/07/2007US20070128158 Cytokine protein family
06/07/2007US20070128157 Tumour suppressor protein
06/07/2007US20070128145 Amino acid adducts for percutaneous delivery of vitamin B3
06/07/2007US20070128133 Incorporating photodamage mitigating agents within the reaction mixture and/or interrogating different observation regions of the reaction mixture for a period that is less than a photodamage threshold period
06/07/2007US20070128126 Airway Alkalinization as Therapy for Airway Diseases
06/07/2007US20070128124 Aerosolized capreomycin for inhibition of pulmonary tuberculosis
06/07/2007US20070128115 Pathological tissue detection and treatment employing targeted benzoindole optical agents
06/07/2007US20070128113 Methods for delivering MBD peptide-linked agent into cells under conditions of cellular stress
06/07/2007US20070125613 Impact absorbent assembly in slope protection systems
06/07/2007CA2671539A1 Methods and compositions for preventing and/or treating pancreatitis
06/07/2007CA2642937A1 Mitigation of photodamage in analytical reactions
06/07/2007CA2632152A1 Neuregulin variants and methods of screening and using thereof
06/07/2007CA2632094A1 Carbonic anhydrase ix (g250) antibodies and methods of use thereof
06/07/2007CA2631760A1 Use of high-dose oxazaphosphorine drugs for treating immune disorders
06/07/2007CA2631731A1 Compounds and methods for inhibiting apoptosis
06/07/2007CA2631587A1 Chemokine-mucin fusions linked to glycosylphosphatidylinositol (gpi)-anchors in tissue regeneration and as tumour immune adjuvants
06/07/2007CA2631524A1 Method for the purification of alpha-1-antitrypsin
06/07/2007CA2631400A1 Process for the production, in prokaryotes, of active, stable transposases of mariner mobile genetic elements
06/07/2007CA2631343A1 The combination of omega-3 fatty acids and thyroid hormone for treating alzheimer's dementia
06/07/2007CA2631181A1 Treatment of conditions involving demyelination
06/07/2007CA2631039A1 Multimeric complexes of antigens and an adjuvant
06/07/2007CA2630578A1 Orally absorbed pharmaceutical formulation and method of administration
06/07/2007CA2628703A1 Anti-a.beta. globulomer antibodies, antigen-binding moieties thereof, corresponding hybridomas, nucleic acids, vectors, host cells, methods of producing said antibodies, compositions comprising said antibodies, uses of said antibodies and methods of using said antibodies
06/07/2007CA2614340A1 Method for determining the concentration of the adipocytic form of the fatty acid binding protein (a-fabp, fabp4, p2)
06/06/2007EP1793000A1 Transgenically produced non-secreted proteins
06/06/2007EP1792992A1 Antigenic protein originating in Malassezia
06/06/2007EP1792991A1 Human CTLA-4 antibodies and their uses
06/06/2007EP1792989A1 13 Transmembrane protein expressed in prostate cancer
06/06/2007EP1792988A2 Compounds and methods for therapy and diagnosis of lung cancer
06/06/2007EP1792983A1 Recombinant alpha-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiences thereof
06/06/2007EP1792917A1 Surface-modified serum albumin-metal porphyrin composite, and oxygen infusion containing the same
06/06/2007EP1792915A2 Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension
06/06/2007EP1792914A1 Chemokine-mucin fusions linked to Glycosylphosphatidylinositol (GPI)-anchors in tissue regeneration and as tumour immune adjuvants
06/06/2007EP1792912A2 Novel proteins and nucleic acids encoding same
1 ... 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 ... 3163